A detailed history of United Advisor Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, United Advisor Group, LLC holds 21,394 shares of BMY stock, worth $1.24 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
21,394
Previous 10,087 112.09%
Holding current value
$1.24 Million
Previous $418,000 164.83%
% of portfolio
0.26%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$39.66 - $51.75 $448,435 - $585,137
11,307 Added 112.09%
21,394 $1.11 Million
Q2 2024

Aug 08, 2024

BUY
$40.25 - $52.99 $7,567 - $9,962
188 Added 1.9%
10,087 $418,000
Q1 2024

May 14, 2024

BUY
$47.98 - $54.4 $474,954 - $538,505
9,899 New
9,899 $536,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track United Advisor Group, LLC Portfolio

Follow United Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Advisor Group, LLC with notifications on news.